Skip to content
Screener

Opko Health OPK EPS (Basic)

EPS (Basic) at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$2.88+14.7%
Regenxbio logo
RegenxbioRGNX
$0.43+131%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$0.47-26.6%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$0.90+23.1%
PTH
Pelthos TherapeuticsPTHS
-$3.09+3.7%
Exelixis logo
ExelixisEXEL
$0.85+25.0%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$985.15M-2.3%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
Line itemFor the three months ended June 30, 2026For the three months ended June 30, 2025For the six months ended June 30, 2026For the six months ended June 30, 2025
Loss before income taxes and investment losses(13,399)(162,520)(74,355)(235,894)
Income tax benefit4,98314,07911,09319,849
Net loss before investment losses(8,416)(148,441)(63,262)(216,045)
Loss from investments in investees(2)(9)
Net loss$(8,416)$(148,441)$(63,264)$(216,054)
Loss per share:
Loss per share, basic and diluted$(0.01)$(0.19)$(0.08)$(0.31)
Weighted average common shares outstanding, basic and diluted755,267,276788,006,992757,061,876700,684,863

Item 1. Financial Statements

FAQ

What is Opko Health's EPS (basic)?
Opko Health (OPK) reported EPS (basic) of -$0.01 in Q2 2026.
How has Opko Health's EPS (basic) changed year-over-year?
Opko Health's EPS (basic) increased by 94.7% year-over-year, from -$0.19 to -$0.01.
What is the long-term trend for Opko Health's EPS (basic)?
Over 4 years (2021 to 2025), Opko Health's EPS (basic) has grown at a 56.5% compound annual growth rate (CAGR), from -$0.05 to -$0.30.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

Ask your AI about Opko Health's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude